Case Western Reserve University's Technology Transfer Office (TTO) serves our innovators with full-spectrum intellectual property services. For both faculty and students, we provide support for intellectual property and commercialization that spans the research & development continuum. We serve our researchers by assessing and building upon the commercial potential of new ideas and inventions.
Through interaction with our inventors, regional and national networks, including our affiliate healthcare systems, and potential commercial partners, we endeavor to determine the best path of translation and ultimate commercialization for University intellectual assets.
Consistent with the University's mission, the Technology Transfer Office is working towards enhancing its role in the promotion of an inclusive culture of global citizenship by exploring issues of access to essential medicines by resource-limited countries. This work includes moving towards the Universities Allied for Essential Medicine's Global Access Licensing Framework.
Lucid Diagnostics, a medtech company with ties to Case Western Reserve University, plans to go public
--Crain's Cleveland, September 27, 2021
PAVmed Subsidiary, Lucid Diagnostics, Files Registration Statement for Proposed Initial Public Offering
--PAVmed, September 23, 2023
PAVmed: A Small Cap Puts Its Streamlined Development Model to the Test
--MyStrategist.com/MedTech-Strategist, August 19, 2020
PAVmed Subsidiary Lucid Diagnostics Launches First Lucid Test Centers
--Business Wire, August 10, 2021
Breakthrough Device ClotChip Moves Forward Toward Production
--PRNewswire, July 22, 2021
Please visit our TTO News webpage for more articles and press releases about TTO success stories.